Twist Bioscience Corp (TWST)
Twist Bioscience Corporation is a biotechnology company listed on the NASDAQ under the ticker TWST. The company develops and sells synthetic DNA-based products, including synthetic genes, gene fragments, oligo pools, immunoglobulin G proteins, and a range of next-generation sequencing tools. Its products are used in therapeutics, diagnostics, chemicals and materials, food and agriculture, data storage, and academic research, with customers spanning biotech and pharmaceutical companies, industrial and agricultural users, and research laboratories. Twist Bioscience also offers methylation detection kits, RNA sequencing workflow solutions, and a variety of synthetic viral controls and research panels for assay development and disease research. In addition, the company provides precision DNA libraries and antibody optimization solutions, and it has a strategic collaboration with bitBiome Inc. Founded in 2013, Twist Bioscience is headquartered in South San Francisco, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TWST
|
$80.98
|
-51.5% Downside
|
Expensive
|
$109.58
|
-34.4% Downside
|
Overvalued
|
Good
|
0.0%
|
November 13, 2026
|
23.5x
|
24.3x
|
10.472 B
|
10.413 B
|
1.1%
|
98.6%
|
22.7
|
68.1%
|
